High growth at low margins is better than the reverse, says Novo Nordisk CEO

Novo Nordisk's growth is a sign of its products' well-being on the market, says CEO Lars Fruergaard Jørgensen. "Growth is the best indicator for future success," he tells Danish media Børsen.
Lars Fruergaard Jørgensen, CEO at Novo Nordisk | Photo: Stine Bidstrup/ERH
Lars Fruergaard Jørgensen, CEO at Novo Nordisk | Photo: Stine Bidstrup/ERH
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

The strongest growth in many years, perhaps ever. This is how CEO at Novo Nordisk Lars Fruergaard Jørgensen describes his firm's current advancements in an interview with Danish business daily Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading